You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site. 

  • The share
  • Arjo B
  • 24 May 2019 18:00
  • 3.24 GBP (-0.85%)

Arjo announces date of 2019 Q1 report and conference call

Arjo will issue its Q1 report for 2019 on Tuesday May 7 at 07:30 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO.

We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference.

Swedish dial-in number: +46 (0)8 5065 3942
UK: +44 (0)330 336 9411
USA: +1 323-794-2093
Participant passcode: 8316273

During the telephone conference, a presentation will be held. To access the presentation, please use this link: https://slideassist.webcasts.com/starthere.jsp?ei=1242715

Alternatively, use the following link to download the presentation: https://www.arjo.com/int/about-us/investors/reports--presentations/2019/

Agenda

07:45             Call in to the conference
08:00             Review of the Q1 report
08.30             Q&A
09.00             End of conference

A recorded version of the conference is accessible for 90 days via the following link: https://slideassist.webcasts.com/starthere.jsp?ei=1242715

For more information, please contact:                                                                                              

Kornelia Rasmussen, EVP Marketing Communications & Public Relations
Tel: +46(0)10 335 4810
E-mail: kornelia.rasmussen@arjo.com

Saloni Deva, Investor Relations & Corporate Communications
Tel: +46 (0) 10 335 4867
Email: saloni.deva@arjo.com

About Arjo

At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has approximately 6,000 employees worldwide and customers in over 100 countries. In 2018, Arjo sales amounted to SEK 8.2 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com

Download as PDF